Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Ultra Short Income ETF (JPST) vs Oscar Health Inc (OSCR) Price & Performance

JPMorgan Ultra Short Income ETFTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

JPMorgan Ultra Short Income ETF vs Oscar Health Inc — how do they compare? JPMorgan Ultra Short Income ETF trades at $50.47, while Oscar Health Inc trades at $29.55 (market cap $8.63B). The key difference: Oscar Health Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.

JPSTOSCR
Sector
Leveraged / InverseHealth
52-Week High
$50.78$32.18
52-Week Low
$50.40$10.85
Market Cap
$8.63B
Enterprise Value
$4.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Ultra Short Income ETF

JPST, the JPMorgan Ultra-Short Income ETF, trades at $50.465, up 0.05% daily, with a bearish technical signal driven by moving averages. The fund focuses on high-quality, short-term bonds, offering a cash alternative with consistent dividends, including recent $0.17 payouts. Institutional holdings have increased, as seen in 13F filings from Financial Management Professionals Inc. and Ashton Thomas Securities LLC in Q2 2026, indicating steady investor interest amid a rising rate environment.

The outlook for JPST is stable, benefiting from its low-risk profile in volatile markets, but faces headwinds from potential Fed rate hikes that could pressure short-term bond yields. Risks include interest rate sensitivity and inflation concerns, yet it remains a core holding for conservative investors seeking yield with minimal volatility.

Oscar Health Inc

Oscar Health (OSCR) trades at $29.11, up 5.2% with strong recent earnings momentum, beating estimates in Q1 and Q2 2026. The stock shows bearish technical signals but benefits from record profitability and raised 2026 guidance. Revenue surged 70% to $4.9 billion in H1 2026, with net income turning positive at $551 million versus a 2025 loss. Valuation remains attractive with P/S of 0.53, suggesting potential undervaluation versus sector peers.

Outlook is positive given membership growth and cost discipline, but risks include medical cost volatility and competitive pressures. Analyst consensus price target of $32.50 implies 12% upside, though technical resistance near $30 may limit near-term gains. Execution on guidance and sustained margin expansion are key catalysts.

Returns comparison

Trailing returns across standard periods

About JPMorgan Ultra Short Income ETF

JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.

Read more on JPST

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR